Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.
Vrijmoeth HD, Ursinus J, Harms MG, Tulen AD, Baarsma ME, van de Schoor FR, Gauw SA, Zomer TP, Vermeeren YM, Ferreira JA, Sprong H, Kremer K, Knoop H, Joosten LAB, Kullberg BJ, Hovius JW, van den Wijngaard CC. Vrijmoeth HD, et al. EBioMedicine. 2023 Dec;98:104825. doi: 10.1016/j.ebiom.2023.104825. Epub 2023 Nov 27. EBioMedicine. 2023. PMID: 38016860 Free PMC article.
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
Vrijmoeth HD, Ursinus J, Harms MG, Zomer TP, Gauw SA, Tulen AD, Kremer K, Sprong H, Knoop H, Vermeeren YM, van Kooten B, Joosten LAB, Kullberg BJ, Hovius JWR, van den Wijngaard CC. Vrijmoeth HD, et al. BMC Infect Dis. 2019 Apr 15;19(1):324. doi: 10.1186/s12879-019-3949-8. BMC Infect Dis. 2019. PMID: 30987580 Free PMC article.
Lyme borreliosis: diagnosis and management.
Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. Kullberg BJ, et al. Among authors: vrijmoeth hd. BMJ. 2020 May 26;369:m1041. doi: 10.1136/bmj.m1041. BMJ. 2020. PMID: 32457042 Review.
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.
Ursinus J, Vrijmoeth HD, Harms MG, Tulen AD, Knoop H, Gauw SA, Zomer TP, Wong A, Friesema IHM, Vermeeren YM, Joosten LAB, Hovius JW, Kullberg BJ, van den Wijngaard CC. Ursinus J, et al. Among authors: vrijmoeth hd. Lancet Reg Health Eur. 2021 May 27;6:100142. doi: 10.1016/j.lanepe.2021.100142. eCollection 2021 Jul. Lancet Reg Health Eur. 2021. PMID: 34557833 Free PMC article.
Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study.
Baarsma ME, van de Schoor FR, Gauw SA, Vrijmoeth HD, Ursinus J, Goudriaan N, Popa CD, Ter Hofstede HJ, Leeflang MM, Kremer K, van den Wijngaard CC, Kullberg BJ, Joosten LA, Hovius JW. Baarsma ME, et al. Among authors: vrijmoeth hd. Lancet Infect Dis. 2022 Sep;22(9):1388-1396. doi: 10.1016/S1473-3099(22)00205-5. Epub 2022 Jun 14. Lancet Infect Dis. 2022. PMID: 35714662
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].
Ursinus J, Vrijmoeth HD, Harms MG, Tulen AD, Knoop H, Gauw SA, Zomer TP, Wong A, Friesema IHM, Vermeeren YM, Joosten LAB, Hovius JW, Kullberg BJ, van den Wijngaard CC. Ursinus J, et al. Among authors: vrijmoeth hd. Lancet Reg Health Eur. 2023 Mar 15;27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr. Lancet Reg Health Eur. 2023. PMID: 36968322 Free PMC article.
Concerns about the external validity of the study 'prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study'-authors´ reply.
van den Wijngaard CC, Ursinus J, Vrijmoeth HD, Knoop H, Wong A, Joosten LAB, Hovius JW, Kullberg BJ. van den Wijngaard CC, et al. Among authors: vrijmoeth hd. Lancet Reg Health Eur. 2022 Mar 22;15:100344. doi: 10.1016/j.lanepe.2022.100344. eCollection 2022 Apr. Lancet Reg Health Eur. 2022. PMID: 35342893 Free PMC article. No abstract available.
Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production.
Kerstholt M, van de Schoor FR, Oosting M, Moorlag SJCFM, Li Y, Jaeger M, van der Heijden WA, Tunjungputri RN, Dos Santos JC, Kischkel B, Vrijmoeth HD, Baarsma ME, Kullberg BJ, Lupse M, Hovius JW, van den Wijngaard CC, Netea MG, de Mast Q, Joosten LAB. Kerstholt M, et al. Among authors: vrijmoeth hd. Clin Exp Immunol. 2022 Oct 21;210(1):53-67. doi: 10.1093/cei/uxac073. Clin Exp Immunol. 2022. PMID: 36001729 Free PMC article.
Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.
van de Schoor FR, Vrijmoeth HD, Brouwer MAE, Ter Hofstede HJM, Lemmers HLM, Dijkstra H, Boahen CK, Oosting M, Kullberg BJ, Hovius JW, van den Wijngaard CC, van de Veerdonk FL, Netea MG, Joosten LAB. van de Schoor FR, et al. Among authors: vrijmoeth hd. Infect Immun. 2022 Mar 17;90(3):e0055821. doi: 10.1128/iai.00558-21. Epub 2022 Feb 7. Infect Immun. 2022. PMID: 35130450 Free PMC article.
17 results